Scientific Opinion on the safety and efficacy of AveMix<sup>®</sup> XG 10 (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) as a feed additive for turkeys for fattening by EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
   EFSA Journal 2013;11(4):3172 
 
Suggested  citation:  EFSA  Panel  on  Additives  and  Products  or  Substances  used  in  Animal  Feed  (FEEDAP);  Scientific 
Opinion on the safety and efficacy of AveMix
® XG 10 (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) as a feed 
additive for turkeys for fattening. EFSA Journal 2013;11(4):3172. [9 pp.] doi:10.2903/j.efsa.2013.3172. Available online: 
www.efsa.europa.eu/efsajournal  
 
© European Food Safety Authority, 2013 
SCIENTIFIC OPINION  
Scientific Opinion on the safety and efficacy of AveMix
® XG 10 (endo-1,4-
beta-xylanase and endo-1,3(4)-beta-glucanase) as a feed additive for  
turkeys for fattening
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The additive AveMix
® XG 10 is an enzyme preparation of endo-1,4-beta-xylanase (xylanase) and endo-1,3(4)-
beta-glucanase (glucanase), produced by two strains of Trichoderma reesei. This product is currently authorised 
for  use  in  chickens  for  fattening,  laying  hens,  minor  poultry  species  and  weaned  piglets  as  a  zootechnical 
additive, under the functional group of digestibility enhancers. The applicant is now seeking an extension of the 
authorisation  to  turkeys  for  fattening  at  a  recommended  dose  of  4 000  XU  (xylanase  units)  and  900  BGU 
(glucanase units) per kg complete feed. The results obtained in a tolerance study in turkeys for fattening showed 
that the birds tolerated well a 100-fold overdose of the recommended dose. Therefore, the additive is safe for 
turkeys for fattening when used at the recommended dose.  Three efficacy studies carried out in turkeys for 
fattening showed that the additive has the potential to be efficacious at the dose of 4 000 XU and 900 BGU/kg 
complete feed. 
© European Food Safety Authority, 2013 
KEY WORDS 
Zootechnical additive, digestibility enhancers, endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase, turkeys for 
fattening, safety, efficacy  
                                                       
1  On request from the European Commission, Question No EFSA-Q-2012-00668, adopted on 12 March 2013. 
2  Panel  members:  Gabriele  Aquilina,  Alex  Bach,  Vasileios Bampidis,  Maria  De  Lourdes Bastos,  Gerhard  Flachowsky, 
Mikolaj Antoni Gralak, Christer Hogstrand, Lubomir Leng, Secundino López-Puente, Giovanna Martelli, Baltasar Mayo, 
Derek Renshaw, Guido Rychen, Maria Saarela, Kristen Sejrsen, Patrick Van Beelen, Robert John Wallace and Johannes 
Westendorf. Correspondence: FEEDAP@efsa.europa.eu 
3  Acknowledgement: The Panel wishes to thank the members of the Working Group on  Enzymes, including Paul Brantom, 
Nuria Canibe, Noël Dierick and Ingrid Halle, for the preparatory work on this scientific opinion.  
 AveMix
® XG 10 for turkeys for fattening  
 
EFSA Journal 2013;11(4):3172  2 
SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of AveMix
® XG 10 (endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase) as a feed additive 
for turkeys for fattening. 
The additive AveMix
® XG 10 is an enzyme preparation of endo-1,4-beta-xylanase (xylanase) and 
endo-1,3(4)-beta-glucanase (glucanase), produced by two strains of Trichoderma reesei. This product 
is currently authorised for use in chickens for fattening, laying hens, minor poultry species and weaned 
piglets as a zootechnical additive, under the functional group of digestibility enhancers. The applicant 
is now seeking an extension of the authorisation to turkeys for fattening  at a recommended dose of 
4 000 XU (xylanase units) and 900 BGU (glucanase units)/kg complete feed.  
A full description of the formulations, manufacturing processes, purity, stability and homogeneity of 
the product has already been provided in a previous assessment. The FEEDAP Panel considers that the 
safety  aspects  other  than  safety  for  the  new  target  species  have  been  covered  in  the  previous 
assessment  and  would  not  be  affected  by  the  requested  extension  of  use.  Therefore,  the  present 
opinion focuses only on the safety and efficacy of this enzyme preparation for the new target species. 
The applicant provided a tolerance study performed in turkeys for fattening. In this study the birds 
tolerated well a 100-fold overdose of the recommended dose (4 000 XU and 900 BGU/kg feed) and 
therefore the Panel concludes that the additive is safe for turkeys for fattening when used at the 
recommended dose.  
Three efficacy studies performed in turkeys for fattening were provided. The supplementation of the 
diets with AveMix
® XG 10 at the recommended dose (4 000 XU and 900 BGU/kg) resulted in a 
significantly higher body weight in two trials and in a significantly improved feed to gain ratio in two 
trials.  Therefore,  the  FEEDAP  Panel  concludes  that  AveMix
®  XG  10  has  the  potential  to  be 
efficacious in turkeys for fattening at the dose of 4 000 XU and 900 BGU/kg feed.  AveMix
® XG 10 for turkeys for fattening  
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BACKGROUND 
Regulation  (EC)  No  1831/2003
4  establishes the rules governing the Community aut horisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7.  
The European Commission received a request from the company AVEVE NV
5 for authorisation of the 
product AveMix
® XG 10, endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase, when used as a 
feed additive for turkeys for fattening (category: zootechnical additives; functional group: digestibility 
enhancers) under the conditions mentioned in Table 1.  
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application  to  the  European  Food  Safety  Authority  (EFSA)  as  an  application  under  Article  4(1) 
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the 
applicant  the  technical  dossier  in  support  of  this  application.
6  According  to  Article  8  of  that 
Regulation, EFSA, after verifying t he particulars and documents submitted by the applicant, shall 
undertake an assessment in order to determine whether the feed additive complies with the conditions 
laid down in Article 5. The particulars and documents in support of the application were con sidered 
valid by EFSA as of 30 July 2012. 
The additive AveMix
® XG 10 is a preparation of endo-1,4-beta-xylanase produced by Trichoderma 
reesei  (MUCL  49755)  and  endo-1,3(4)-beta-glucanase  produced  by  Trichoderma  reesei  (MUCL 
49754).  This  product  is  currently  authorised  for  use  as  feed  additive  in  feed  for  chickens  for 
fattening
7,8 weaned piglets,
9 and laying hens and minor poultry species for fattening and laying.
10 
The European Food Safety Authority issued a scientific opinion on the safety and efficacy of AveMix
® 
XG 10 as a feed additive for chickens for fattening (EFSA, 2009) and one on the modification of the 
terms of the authorisation of the product for this species (EFSA, 2010). Opinions on the safety and 
efficacy of the product as a feed additive for weaned piglets and laying hens and minor poultry species 
were published on 2011 and 2012, respectively (EFSA, 2011 and 2012).  
TERMS OF REFERENCE 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of the product 
                                                       
4   Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5   AVEVE NV, Minderbroedersstraat 8, 3000 Leuven, Belgium. 
6   EFSA Dossier reference: FAD-2012-0019. 
7  Commission Regulation (EC) No 1091/2009 of 13 November 2009 concerning the authorisation of an enzyme preparation 
of endo-1,4-beta-xylanase produced by Trichoderma reesei (MUCL 49755) and endo-1,3(4)-beta-glucanase produced by 
Trichoderma reesei (MUCL 49754) as a feed additive for chickens for fattening (holder of authorisation Aveve NV) OJ L 
299, 14.11.2009, p. 6. 
8  Commission Regulation (EU) No 335/2011  of 7 April 2011 amending Regulation (EC) No 1091/2009 as regards the 
minimum content of the enzyme preparation of endo -1,4-beta-xylanase produced by Trichoderma reesei (MUCL 49755) 
and endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (MUCL 49754) as a feed additive in feed for chickens for 
fattening OJ L 94, 08.04.2011, p. 14. 
9  Commission Implementing Regulation (EU) No 1088/2011 of 27 October 2011 concerning the authorisation of an enzyme 
preparation of endo-1,4-beta-xylanase produced by Trichoderma reesei (MULC 49755) and endo-1,3(4)-beta-glucanase 
produced by Trichoderma reesei (MULC 49754) as a feed additive for weaned piglets (holder of authorisation Aveve NV) 
OJL 281, 28.10.2011, p. 14. 
10 Commission Implementing Regulation (EU) No 989/2012 of 25  October 2012 concerning the authorisation of endo -1,4-
beta-xylanase produced by Trichoderma reesei (MUCL 49755) and endo-1,3(4)-beta-glucanase produced by Trichoderma 
reesei  (MUCL 49754) as a feed additive for laying hens and minor poultry species for fattening and laying (holder of 
authorisation Aveve NV). OJ L 297, 26.10.2012, p. 11. AveMix
® XG 10 for turkeys for fattening  
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AveMix
®  XG  10,  endo-1,4-beta-xylanase  and  endo-1,3(4)-beta-glucanase,  when  used  under  the 
conditions described in Table 1. AveMix
® XG 10 for turkeys for fattening  
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Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive   endo-1,4-beta-xylanase  EC  3.2.1.8  and  endo-1,3(4)-beta-glucanase  EC 
3.2.1.6 (AveMix
® XG 10) 
Registration number/EC 
No/No (if appropriate)  4a9 
Category(-ies) of additive  Zootechnical additive 
Functional group(s) of additive  Digestibility enhancer 
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
(if appropriate) 
Method of analysis 
(if appropriate) 
Enzyme  preparation  containing 
endo-1,4-beta-xylanase  (EC 
3.2.1.8)  produced  by 
Trichoderma  reesei  and  endo-
1,3(4)-beta-glucanase  (EC 
3.2.1.6)  produced  by 
Trichoderma  reesei.  Solid  or 
liquid  having  a  minimum 
activity  of  endo-1,4-beta-
xylanase: 40000 XU/g endo-1,3-
(4)-beta-glucanase: 9000 BGU/g 
Not applicable 
Complies  with  JECFA 
guidelines on microbial 
quality,  heavy  metals, 
toxins  and  undesirable 
substances 
Assay based on colometric 
reaction  of  dinitrosalicylic 
acid  on  reducing  sugar 
yield produced by action of 
endo-1,4-beta-xylanase on a 
xylan  containing  substrate 
or  endo-1,3(4)-beta-
glucanase on a beta-glucan 
containing substrate 
 
Trade name (if appropriate)  AveMix
® XG 10 
Name of the holder of 
authorisation (if appropriate)  AVEVE NV 
 
Conditions of use 
Species  or 
category  of 
animal 
Maximum 
Age 
Minimum content  Maximum content  Withdrawal 
period 
(if appropriate)  U/kg of complete feedingstuffs 
Turkeys for 
fattening 
Until 
slaughter 
age 
Endo-1,4-beta-
xylanase:  4000  XU/kg 
complete feed endo-1,3-
(4)-beta-glucanase:  900 
BGU/kg complete feed 
  Not relevant 
 
Other provisions and additional requirements for the labeling 
Specific conditions or restrictions for 
use (if appropriate) 
In the direction for use of the additive and premixture, indicate the 
storage temperature, storage life, and stability to pelleting 
Specific conditions or restrictions for 
handling (if appropriate)  - 
Post-market monitoring  
(if appropriate)  - 
Specific conditions for use in 
complementary feedingstuffs  
(if appropriate) 
Recommended dosages per kilogram of complete feedingstuff for 
turkeys  for  fattening:  endo-1,4-beta-xylanase:  4000  XU,  endo-
1,3(4)-beta-glucanase: 900 BGU 
 
Maximum Residue Limit (MRL) (if appropriate) 
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
-  -  -  - AveMix
® XG 10 for turkeys for fattening  
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ASSESSMENT 
1.  Introduction 
The additive AveMix
® XG 10 is an enzyme preparation of endo-1,4-beta-xylanase (xylanase; EC 
3.2.1.8)  and  endo-1,3(4)-beta-glucanase  (glucanase;  EC  3.2.1.6),  produced  by  two  strains  of 
Trichoderma reesei (MUCL 49755 and 49754, respectively). The product is produced in two forms, 
solid and liquid, with an activity of xylanase of 40 000 XU/g and of glucanase of 9 000 BGU/g. This 
product is currently authorised for its use in feed for chickens for fattening, laying hens and minor 
poultry  species  and  weaned  piglets  as  a  zootechnical  additive,  under  the  functional  group  of 
digestibility enhancers. The applicant is now seeking the authorisation of the product as feed additive 
for  turkeys  for  fattening  at  a  recommended  dose  of  4 000  XU  (xylanase  units)  and  900  BGU 
(glucanase units) per kg complete feed (delivered by 100 mg additive/kg feed).  
The European Food Safety Authority issued two scientific opinions on the safety and efficacy of 
AveMix
® XG 10 as a feed additive for chickens for fattening (EFSA, 2009, 2010), another one for its 
use in weaned piglets (EFSA, 2011) and a fourth on its use in laying hens and minor poultry species 
(EFSA, 2012). A full description of the formulations, manufacturing processes, purity, stability and 
homogeneity of the product has already been provided in a previous assessment (EFSA, 2009). The 
FEEDAP Panel considers that the safety aspects other than safety for the new target species have been 
covered in this previous assessment and would not be affected by the requested extension of use. 
Therefore, the present opinion focuses only on the safety and efficacy of this enzyme preparation for 
the new target species. 
2.  Evaluation of the analytical methods by the European Union Reference Laboratory 
(EURL) 
The EURL considered that the conclusions and recommendations reached in the previous assessment 
are valid and applicable for the current application.
11  
3.  Safety for turkeys for fattening 
A total of 1 500 one-day-old Big-9 female turkeys were distributed in replicates of 31 or 32 birds and 
allocated to four dietary treatments (12 replicates per treatment).
12 On day 28 the number of birds per 
replicate was reduced to 25. Basal diets based on wheat and soya bean meal were sup plemented with 
AveMix
® XG 10 to provide 0/0, 3 000/675 (0.75×), 4 000/900 (1×) and 400 000/90 000 (100×) XU 
and BGU/kg feed, respectively (confirmed by analyses). Diets contained monensin until eight weeks 
of age and were offered as crumbs until day 28 and thereafter as pellets. The study lasted 84 days and 
performance  of  the  birds  was  measured.  Performance  data  were  subject  to  analysis  of  variance 
(ANOVA) and a Dunnett test to compare the means.
13 
Mortality ranged from 0.8 % to 1.6 % without differences between the treatments (see Table 3). This 
figure does not include runt birds that were culled during the first two weeks (3, 3, 8  and 9 in the 0, 
0.75×, 1× and 100× group, respectively). Mean body weight was 59 g initially and after 84 days was 
7.36, 7.46, 7.52 and 7.46 kg in the four groups. Average daily gain was 87, 88, 89 and 88 g and  the 
corresponding feed to gain ratio was 2.14, 2.10, 2.09 and 2.07 (feed to gain ratio values in the 1× and 
100× were significantly different from the 0/0 group). The animals tolerated well a dose of 100× the 
recommended dose; thus, the Panel concludes that the additive is safe for the turkeys for fattening at 
the recommended dose. 
                                                       
11   The  full  report  is  available on  the  EURL  website:  http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-
2009-0062.pdf 
12   Technical dossier/Section III/Annex III.2.1 and supplementary information December 2012/Annex 1. 
13   Technical dossier/Supplementary information February 2013/Annex 2. AveMix
® XG 10 for turkeys for fattening  
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4.  Efficacy for turkeys for fattening 
Three performance trials conducted in three different countries were provided. The design of the trials 
is presented in Table 2 and a summary of the results in Table 3.  
The third trial is the tolerance trial reported above. In all cases, one-day-old birds were used, and were 
under  study  for  84  days.  Males  were  used  in  trials  1  and  2  and  females  in  trial  3.  The  dietary 
treatments resulted from the supplementation of basal diets with AveMix
® XG 10 (solid) at different 
dosages. The intended doses were confirmed by analyses. Diets in trial 1 and 2 were offered as pellets, 
in trial 3 as crumbs until day 28 and thereafter as pellets. General health status and mortality were 
monitored and performance of the animals was measured. Data was subject to an ANOVA followed 
by a Tukey (trial 1) or a Dunnett test (trials 2 and 3) in order to compare group means. 
Table 2:   Summary of the design of the three performance trials in turkeys for fattening considered 
for the assessment 
Trial 
AveMix
® XG 10 (U/kg)
1  Diet 
composition 
Breed 
(sex) 
Total no of animals 
(animals/replicate) 
replicates/treatment
2  Intended  Analysed 
1
14 
0/0 
2 000/450 
4 000/900 
–/– 
2 214/528 
4 350/1 008 
Wheat, rye, 
soya bean meal 
BUT 6 
(♂) 
600 
(10) 
20 
2
15 
0/0 
2 000/450 
4 000/900 
–/– 
2 330/523 
4 815/1 051 
Wheat, barley, 
soya bean meal 
BUT  
(♂) 
360 
(12) 
10 
3
16 
0/0 
3 000/675 
4 000/900 
400 000/90 000 
–/– 
3 260/702 
4 427/933 
466 488/108 40
4 
Wheat, soya 
bean meal 
Big-9 
(♀) 
1500 
(12) 
31-32 
1 Values for xylanase/glucanase, analysed values for the non-supplemented diets were not provided. 
2 In trial 3 the number of animals per pen was reduced to 25 birds on day 28. 
Table 3:   Effect of AveMix
® XG 10 on the performance of turkeys for fattening 
Trial 
 
AveMix
® XG 10 
(U/kg)
1 
Body weight (g)  Daily feed 
intake (g) 
Feed to gain 
ratio 
Mortality
2 
(%) 
Initial   Final 
1 
0/0 
2 000/450 
4 000/900 
60.4 
60.4 
60.4 
10 953
a 
11 015
ab 
11 199
b 
253 
250 
253
 
1.95
a 
1.92
b 
1.91
b 
5.8 
2.5 
4.0 
2 
0/0 
2 000/450 
4 000/900 
61 
62 
60 
10 457 
10 511 
10 542
* 
250 
248 
249 
2.02  
1.99 
1.99 
0 
2.5 
1.7 
3 
0/0 
3 000/675 
4 000/900 
400 000/90 000 
59 
59 
59 
59 
7 361 
7 464 
7 517 
7 463 
186 
185 
185 
183 
2.14 
2.10 
2.09
* 
2.07
* 
0.8 
1.6 
1.6 
1.1 
1  Intended dose for xylanase/glucanase. 
2  In trial 1 values do not consider the animals that died during the first week, in trial 3 values do not consider dead animals 
during the two initial weeks. 
a,bValues in one column and within a given trial with different superscripts are significantly different (P < 0.05). 
* Values are different from the control diet (P < 0.05). 
                                                       
14   Technical dossier/Section IV/Annex IV.2.11 and supplementary information December 2012. 
15   Technical dossier/Section IV/Annex IV.2.12 and supplementary information February 2013/Annex 3. 
16   Technical dossier/Section IV/Annex IV.2.13 and supplementary information February 2013/Annex 2. AveMix
® XG 10 for turkeys for fattening  
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Mortality was low (< 6 %) and not related to the experimental treatments. The supplementation of the 
basal diet with AveMix
® XG 10 at the recommended dose of 4 000 XU and 900 BGU/kg feed resulted 
in a higher final body weight in trials 1 and 2 and a better feed to gain ratio in trials 1 and 3. Therefore, 
the Panel concludes that the additive has the potential to improve the performance of turkeys for 
fattening at the recommended dose. 
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
17  and  Good 
Manufacturing Practice. 
CONCLUSIONS  
The two formulations (liquid and solid) of the additive are considered to be equivalent regarding the 
safety and efficacy for the target species when used at the same level. 
Based on the results obtained in a tolerance study with turkeys for fattening, in which birds tolerated 
well a 100-fold overdose of the recommended dose, the FEEDAP Panel concludes that the additive is 
safe for turkeys for fattening at the recommended dose. 
Supplementation of feed with AveMix
® XG 10 at the recommended dose (4 000 XU and 900 BGU/kg 
feed) resulted in a better performance of turkeys for fattening in three trials. Therefore, the Panel 
concludes that the additive has the potential to be efficacious in turkeys for fattening at this dose. 
DOCUMENTATION PROVIDED TO EFSA 
1.  AveMix
® XG 10 turkeys for fattening. May 2012. Submitted by AVEVE NV. 
2.  AveMix
® XG 10 turkeys for fattening. Supplementary information. December 2012. Submitted by 
AVEVE NV. 
3.  AveMix
® XG 10 turkeys for fattening. Supplementary information. February 2013. Submitted by 
AVEVE NV. 
4.  Comments from Member States received through the ScienceNet. 
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